Wegovy (semaglutide) Wegovy is an injection containing the active ingredient semaglutide, a glucagon-like-peptide-1 (GLP-1) receptor agonist
That is especially true if you are eating smaller portions, skipping meals unintentionally, or feeling full quickly
Semaglutide Tirzepatide FAQ Find answers to common questions about compounded semaglutide, from eligibility and dosing to storage and payment
A prespecified analysis of pooled data from the STEP-HFpEF and STEP-HFpEF DM trials demonstrated that significantly more patients treated with Wegovy 2.4 mg SC once weekly had an improvement of at least one New York Heart Association (NYHA) functional class compared to those who received placebo (32.6% versus 21.5%, respectively
While both the brand name version and the generics use the same active ingredient semaglutide in a once-weekly injection, they are made differently
Many of our patients report feeling more alert and focused after starting these injections